Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theobromine Supplementation in Metabolic Syndrome
IRCT20091114002709N59Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of theobromine in cardiometabolic risk (CMR), sponsored by Iran University of Medical Sciences. Primary endpoints: Anthropometric indices, Glycemic indices and 2 more. Started Jan 2022; status: completed.
02
Drugs
theobromine
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT20091114002709N59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091114002709N59.